RecruitingNCT06498167
Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib)
Studying Rare intoxication due to medical products
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Universidade do Porto
- Principal Investigator
- Inês Ribeiro Vaz, PharmD, MPH, PhDUniversidade do Porto
- Intervention
- Upadacitinib(drug)
- Enrollment
- 150 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2024
Study locations (3)
- Unidade Local de Saúde de Santo António, E.P.E., Porto, Portugal
- Unidade Local de Saúde de São João, E.P.E., Porto, Portugal
- Unidade Local de Saúde de Gaia/Espinho, E.P.E., Porto, Portugal
Collaborators
INFARMED - Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. · Unidade de Farmacovigilância do Porto · Unidade Local de Saúde São João · Unidade Local de Saúde de Santo António, E.P.E. · Unidade Local de Saude de Gaia e Espinho EPE · RISE Health
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06498167 on ClinicalTrials.gov